chr1-62663044-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001367561.1(DOCK7):​c.125A>G​(p.Asn42Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000234 in 1,613,560 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0012 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

DOCK7
NM_001367561.1 missense

Scores

19

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0510

Publications

1 publications found
Variant links:
Genes affected
DOCK7 (HGNC:19190): (dedicator of cytokinesis 7) The protein encoded by this gene is a guanine nucleotide exchange factor (GEF) that plays a role in axon formation and neuronal polarization. The encoded protein displays GEF activity toward RAC1 and RAC3 Rho small GTPases but not toward CDC42. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
DOCK7 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 23
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0067307055).
BP6
Variant 1-62663044-T-C is Benign according to our data. Variant chr1-62663044-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475123.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00125 (190/152236) while in subpopulation AFR AF = 0.0039 (162/41544). AF 95% confidence interval is 0.00341. There are 2 homozygotes in GnomAd4. There are 81 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DOCK7NM_001367561.1 linkc.125A>G p.Asn42Ser missense_variant Exon 2 of 50 ENST00000635253.2 NP_001354490.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DOCK7ENST00000635253.2 linkc.125A>G p.Asn42Ser missense_variant Exon 2 of 50 5 NM_001367561.1 ENSP00000489124.1 Q96N67-1

Frequencies

GnomAD3 genomes
AF:
0.00124
AC:
189
AN:
152116
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00389
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.000314
AC:
79
AN:
251338
AF XY:
0.000265
show subpopulations
Gnomad AFR exome
AF:
0.00357
Gnomad AMR exome
AF:
0.000318
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000528
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000128
AC:
187
AN:
1461324
Hom.:
0
Cov.:
31
AF XY:
0.000114
AC XY:
83
AN XY:
726980
show subpopulations
African (AFR)
AF:
0.00362
AC:
121
AN:
33464
American (AMR)
AF:
0.000403
AC:
18
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86218
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000234
AC:
26
AN:
1111588
Other (OTH)
AF:
0.000315
AC:
19
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00125
AC:
190
AN:
152236
Hom.:
2
Cov.:
32
AF XY:
0.00109
AC XY:
81
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00390
AC:
162
AN:
41544
American (AMR)
AF:
0.00131
AC:
20
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000416
AC:
2
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68010
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000440
Hom.:
0
Bravo
AF:
0.00145
ESP6500AA
AF:
0.00409
AC:
18
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000428
AC:
52
EpiCase
AF:
0.0000546
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 23 Benign:2
Jan 12, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Apr 07, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Feb 20, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

DOCK7-related disorder Benign:1
Nov 11, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
5.9
DANN
Benign
0.42
DEOGEN2
Benign
0.062
.;.;.;.;.;T;.
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.84
T;T;T;T;T;T;T
M_CAP
Benign
0.0039
T
MetaRNN
Benign
0.0067
T;T;T;T;T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-0.28
N;N;N;N;N;N;N
PhyloP100
0.051
PrimateAI
Benign
0.40
T
PROVEAN
Benign
0.23
N;.;N;.;.;.;N
REVEL
Benign
0.079
Sift
Benign
1.0
T;.;T;.;.;.;T
Sift4G
Benign
1.0
T;T;T;T;T;T;T
Polyphen
0.0
.;B;B;.;.;.;.
Vest4
0.10
MVP
0.19
MPC
0.31
ClinPred
0.0029
T
GERP RS
-2.3
PromoterAI
0.010
Neutral
Varity_R
0.040
gMVP
0.25
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143701798; hg19: chr1-63128715; API